Drug Shortage Report for FOQUEST
Report ID | 151791 |
Drug Identification Number | 02470357 |
Brand name | FOQUEST |
Common or Proper name | methylphenidate hydrochloride Controlled Release Capsules |
Company Name | ELVIUM LIFE SCIENCES |
Market Status | MARKETED |
Active Ingredient(s) | METHYLPHENIDATE HYDROCHLORIDE |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE (CONTROLLED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 60 |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-01-07 |
Actual start date | 2022-01-05 |
Estimated end date | 2024-09-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-05-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v101 | 2023-04-21 | French | Compare |
v102 | 2023-05-01 | English | Compare |
v103 | 2023-05-01 | French | Compare |
v104 | 2023-05-04 | English | Compare |
v105 | 2023-05-04 | French | Compare |
v106 | 2023-05-05 | English | Compare |
v107 | 2023-05-05 | French | Compare |
v108 | 2023-05-12 | English | Compare |
v109 | 2023-05-12 | French | Compare |
v110 | 2023-05-18 | English | Compare |
v111 | 2023-05-18 | French | Compare |
v112 | 2023-05-26 | English | Compare |
v113 | 2023-05-26 | French | Compare |
v114 | 2023-06-08 | English | Compare |
v115 | 2023-06-08 | French | Compare |
v116 | 2023-06-09 | English | Compare |
v117 | 2023-06-09 | French | Compare |
v118 | 2023-06-15 | English | Compare |
v119 | 2023-06-15 | French | Compare |
v120 | 2023-06-27 | English | Compare |